Aripiprazole in the Treatment of Acutely Relapsed Patients With Schizophrenia

Clinical trial NCT00283179 · COMPLETED

Trial details

NCT number: NCT00283179
Sponsor: Taiwan Otsuka Pharm. Co., Ltd
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Schizophrenia Schizoaffective Disorder

Start date: 2004-03-01
Enrollment: 83

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.